MAPK3 and neoplasm: Particularly, our data is consistent with our previous finding that the pro-proliferation signalling, such as the activation of MAP kinase (i.e. phospho-ERK1/2), was significantly reduced in tumor tissues but not in normal lung tissues after EGCG treatment [19,20].